Literature DB >> 16864955

High prevalence of gastroesophageal reflux disease with minimal mucosal change in asthmatic patients.

Yasuo Shimizu1, Kunio Dobashi, Setsuo Kobayashi, Ichiro Ohki, Masahiko Tokushima, Motoyasu Kusano, Osamu Kawamura, Yasuyuki Shimoyama, Mitsuyoshi Utsugi, Masatomo Mori.   

Abstract

It is known that the prevalence of gastroesophageal reflux disease (GERD) in asthmatic patients is high. Although an endoscopic diagnosis of GERD based on the established Los Angeles (LA) classification requires the detection of erosive mucosal breaks, there are patients with GERD who have prominent erythema of the esophageal membrane without erosive mucosal breaks. Non-erosive mucosal change denotes the minimal change of the discoloring type of reflux esophagitis. This study was undertaken to determine the prevalence of GERD in asthmatic patients using the LA classification with the inclusion of minimal change, compared to the prevalence determined using the established LA classification without minimal change. The presence of GERD in asthmatic patients (n = 78), non-asthmatic disease control patients (n = 56), and healthy subjects (n = 150) was evaluated by endoscopic examination. The frequency of GERD in asthmatic patients based on the LA classification with minimal change was higher (54/78, 69.2%) than in asthmatic patients based on the LA classification without minimal change (37/78, 47.4%) (p < 0.05). The prevalence of GERD in asthmatic patients (69.2%) was higher than that in disease control patients (17/56, 30.4%) and healthy subjects (27/150, 18.0%) based on the LA classification with minimum change. These data indicate that asthmatic patients have a high frequency of GERD. In addition, without the inclusion of minimum change to the diagnosis of GERD, the prevalence of GERD appears to be underestimated in asthmatic patients. Therefore, physicians should carefully observe asthmatic patients with minimal change on endoscopy.

Entities:  

Mesh:

Year:  2006        PMID: 16864955     DOI: 10.1620/tjem.209.329

Source DB:  PubMed          Journal:  Tohoku J Exp Med        ISSN: 0040-8727            Impact factor:   1.848


  8 in total

1.  Gastroesophageal reflux in children with refractory asthma.

Authors:  Alaa S Deeb; Amal Al-Hakeem; Ghazal S Dib
Journal:  Oman Med J       Date:  2010-07

2.  Epidemiology of gastroesophageal reflux disease in Asia: a systematic review.

Authors:  Hye-Kyung Jung
Journal:  J Neurogastroenterol Motil       Date:  2011-01-26       Impact factor: 4.924

3.  Prevalence of gastro-oesophageal reflux disease symptoms and reflux-associated respiratory symptoms in asthma.

Authors:  Lakmali D Amarasiri; Arunasalam Pathmeswaran; H Janaka de Silva; Channa D Ranasinha
Journal:  BMC Pulm Med       Date:  2010-09-15       Impact factor: 3.317

Review 4.  Epidemiology and clinical characteristics of GERD in the Japanese population.

Authors:  Yasuhiro Fujiwara; Tetsuo Arakawa
Journal:  J Gastroenterol       Date:  2009-04-14       Impact factor: 7.527

Review 5.  The association between gastro-oesophageal reflux disease and asthma: a systematic review.

Authors:  B D Havemann; C A Henderson; H B El-Serag
Journal:  Gut       Date:  2007-08-06       Impact factor: 23.059

6.  Esophageal motility, vagal function and gastroesophageal reflux in a cohort of adult asthmatics.

Authors:  D Lakmali Amarasiri; Arunasalam Pathmeswaran; Anuradha S Dassanayake; Arjuna P de Silva; Channa D Ranasinha; H Janaka de Silva
Journal:  BMC Gastroenterol       Date:  2012-10-12       Impact factor: 3.067

7.  Different gastoroesophageal reflux symptoms of middle-aged to elderly asthma and chronic obstructive pulmonary disease (COPD) patients.

Authors:  Yasuo Shimizu; Kunio Dobashi; Motoyasu Kusano; Masatomo Mori
Journal:  J Clin Biochem Nutr       Date:  2011-11-11       Impact factor: 3.114

8.  Exhaled breath marker in asthma patients with gastroesophageal reflux disease.

Authors:  Yasuo Shimizu; Kunio Dobashi; Masatomo Mori
Journal:  J Clin Biochem Nutr       Date:  2007-11       Impact factor: 3.114

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.